No Data
No Data
Insider decrases its stake in Heartseed(219A.JP) to 7.11%
On Oct 4, Angel Bridge Deal―by―Deal Fund5号株式会社 submitted the Change Report to Ministry of Finance. The report shows that Angel Bridge Deal―by―Deal Fund5号株式会社 decreased their holdings in $Heartseed(219
Volume change rate ranking (9:00) - World, Enechange, etc. ranked in.
In the volume change rate ranking, by comparing the average volume of the past 5 days with the volume on the delivery day, you can understand the interests of market participants such as trend of speculation. Top volume change rate [As of October 4, 9:32] (Comparison of average volume of the past 5 days) Stock Code Stock Name Volume 5-Day Average Volume Volume Change Rate Stock Price Change Rate <2856> US bond 37H 284,460 107,185.08 302.27% -0.00
Stocks that moved the previous day part2: Ikuyo, Sailor Advertisement, Baby Calendar, etc.
Stock Name <Code> 2nd Closing Price ⇒ Day-on-day Change * Laser Tech <6920> 22785 -1150 The U.S. SOX index dropped nearly 3%. * PKSHA Technology <3993> 3370 -220 Despite the increase in price after being designated as Prime. * KOKUSAI ELECTRIC <6525> 3130 -135 Semiconductor manufacturing equipment overall selling predominates in a risk-off environment. * Japan Micronics <6871> 3810 -295 Softness in semiconductor-related sector.
Emerging markets stock digest: Jelbins significantly extended, Rainfall Sunlight hit the daily limit
<150A> JSH 621 -1 deadlock. It has been announced that a new branch of the home medical care business, 'Visiting Nurse Station Cordiale Edogawa Sales Office,' has been established in Edogawa-ku, Tokyo. 'Visiting Nurse Station Cordiale' is a psychiatric home visit medical support service office. The number of psychiatric patients is increasing year by year, and the demand for home medical care that can be received at home is expanding, so efforts are being made to expand the area. <206A> PRISMBio 415 -39
Heartseed and others continue to rank in, with the review of the first case in the high-dose group completed in a study of iPS cell-derived cardiomyocytes from other households.
Heartseed <219A> ranked in (as of 10:32). Significantly extended. After the end of the previous day's trading, it was announced that the safety review by the safety evaluation committee of the first high-dose group for severe heart failure associated with ischemic heart disease using iPS cell-derived myocardial spheres (HS-001) in the phase 1/2 trial (LAPiS trial) was completed. Following the completion of the review, it became possible to continue dosing in the high-dose group. Top changes in volume ratio [October 1st 10:32 current] (last 5
Volume change rate ranking (9 o'clock) - Rain, wind, sun, Jellybee, etc. ranked in.
In the volume change rate ranking, by comparing the average volume of the past 5 days with the volume on the delivery date, you can understand the interests of market participants such as market trends. Top volume change rate [As of 9:32 on October 2] (comparison with the average volume of the past 5 days) Stock Code Stock Name Volume 5-Day Average Volume Volume Change Rate Stock Price Change Rate <3070> Jellybee 3127900 107185.08 305.84% 0.19
No Data
No Data